head and neck cancer, squamous cell carcinoma, Radiotherapy, Cisplatin, EGFR inhibition, randomised, phase III, DAHANCA
Radiotherapy (RT), Head and neck squamous cell carcinoma (HNSCC), Pattern of failure, Human papilloma virus (HPV)/p16, radiobiology, Radioresistance, Deformable image registration (DIR), Point of origin